- GSK, Hansoh ADC extends survival in lung cancer studyGSK claimed the result was a first for an ADC aimed at the “B7-H3” protein, an increasingly popular target of late among cancer drugmakers.BioPharma Dive · 18d ago↗ source
- STAT+: Roche ends Huntington’s gene-silencing programsARPA-H launches bespoke gene therapy push, Lilly and Novo to promote Bridge program, and more biotech news from The ReadoutSTAT · 18d ago↗ source
- STAT+: Pharmalittle: We’re reading about bigger drug discounts in Germany, drugmakers embracing secrecy, and moreGerman lawmakers passed a bill that would more than double the discount on branded medicines drugmakers must provide the governmentSTAT · 18d ago↗ source